Anna Salamero Boix
Anna Salamero Boix completed her Bachelor's and Master's degree in Biomedical Sciences at the University of Lleida and the Autonomous University in Madrid (Spain). During her bachelor's and master's thesis in Dr. Squatrito's laboratory at the CNIO in Madrid (Spain), Anna worked on the identification of resistance to temozolomide in glioblastoma multiforme. As part of her doctoral research, Anna is studying anti-inflammatory signaling pathways in brain metastases in the lab of Dr. Sevenich.
Dr. Michael Schulz
Dr. Michael Schulz trained as biologist at the University of Bayreuth, where he did his bachelor and finished his master in 2015, working on pigment cell development in zebrafish. In November 2015, he joined the newly founded group of Dr. Lisa Sevenich for his doctoral thesis. During his PhD he examined the tumor microenvironment of preclinical models of brain metastases on the molecular and cellular level, focussing on tumor-associated macrophages and microglia, as well as whole-brain radiotherapy. After finishing his PhD in September 2021, Michael will continue his work in the Sevenich lab as a PostDoc to further study different aspects of the glial-neuronal-tumor cell crosstalk within the brain metastasis microenvironment.
Julian Anthes received his Bachelor degree in Biology from the Philipps-University of Marburg. During his Bachelor thesis in the group of Prof. Dr. Jude Przyborski, he worked on the protein translocation in with Plasmodium falciparum infected red blood cells. Julian joined the AG Sevenich as a Master student in 2019 within the molecular medicine studies at the Goethe-University of Frankfurt am Main. In his thesis he analyzed effects of macrophage depletion on radio-immunotherapy in breast-to-brain metastasis. In his PhD project his main research focuses on the effect of immune-checkpoint inhibitors to improve the standard-of-care treatment to develop adjuvant therapies for brain metastases.
Dominic Menger studied Applied Biology for Medicine and Pharmacy at the Fresenius University of Applied Sciences in Idstein. In his bachelor thesis he investigated inflammation-induced changes in megakaryocytes and platelets in the group of Prof. Dr. Klaus Scholich at the Institute of Clinical Pharmacology at the University Hospital of the Goethe University Frankfurt am Main. Then he studied the master's degree in molecular medicine at the Goethe University in Frankfurt am Main. In the master's thesis in the working group of Dr. Lisa Sevenich he examined the role of colony stimulating factor 2 (CSF2) on macrophages and microglia in a breast-to-brain metastasis model. Starting his doctoral thesis in the group of Dr. Lisa Sevenich in May 2021, Dominic will focus on the role and formation of lymphatic vessels in the recruitment of T cells in brain metastases.
Aylin Möckl studied molecular biology at the Johannes Gutenberg University in Mainz. During her bachelor thesis in the group of Prof. Dr. Ari Waisman, she investigated the role of the Nf-κB signaling pathway in multiple sclerosis. She completed her master's degree in molecular medicine at the Goethe University in Frankfurt am Main. During her master thesis in the group of Dr. Lisa Sevenich, Aylin investigated the role of specific genes in the development of brain metastases for the generation of a spontaneous breast-to-brain metastasis model. In April 2020 she started her PhD in the group of Dr. Lisa Sevenich and investigates the effects of CSF1 and CSF2 on brain metastasis.
Anna Wolfram completed her Bachelor's and Master's degree in Biochemistry at the University of Heidelberg. Anne specialized on the multidisciplinary process of drug design in both her bachelor's and master's thesis. For the former, she worked on hypoxia activated prodrugs in the Translational Therapeutics Team (ACSRC, New Zealand). For the later, Anna worked on the synthetic route of phosphaphenalene gold (I) agents – a novel anti-glioblastoma class – in the Carlos Romero-Nieto Research Group (UCLM, Spain and University of Heidelberg). As part of her doctoral research, Anna aims to unveil the mode(s) of action of phosphaphenalene gold (I) agents in the tumor microenvironment. Anna also holds a Master of Business Administration.